etrials Adds Three New Trials for Top Ten Pharmaceutical Clients Company Supplies Patient Diary Technology to Over 4,000 New Patients
etrials Worldwide, Inc., the first company to offer fully integrated, easy-to-use eClinical software for the clinical trial process, today announced that it has added three new studies for top ten pharmaceutical companies. All three trials will use etrials' electronic patient diary technology on handheld devices (PDAs) to electronically capture patient reported outcomes (ePRO).
etrials Worldwide, Inc., the first company to offer fully integrated, easy-to-use eClinical software for the clinical trial process, today announced that it has added three new studies for top ten pharmaceutical companies. All three trials will use etrials' electronic patient diary technology on handheld devices (PDAs) to electronically capture patient reported outcomes (ePRO).
Two of the new studies are Phase III, women's health trials which will include 300 sites and approximately 4,000 patients. The third new trial is a Phase IIIb Neurology study which will include 20 sites and over 300 patients. etrials? ePRO devices will be distributed to patients participating in the studies to record and submit trial data remotely as well as used for site-based collection of data.
"As more emphasis is placed on faster access to critical patient data we have seen many of the top pharmaceutical companies making great strides in implementing eClinical technology in a variety of studies, across multiple trials and in all therapeutic areas," said John Cline, CEO of etrials. "Having the opportunity to work with many of the top ten pharmaceutical companies enables etrials to further demonstrate its unique ability to offer fully integrated and easy-to-use technology and the important efficiencies gained through the use of eClinical technology."
About etrials Worldwide, Inc.
etrials is a software and services company dedicated to making eClinical easy. We are the first company to offer a fully integrated suite of eClinical software including electronic data capture (EDC), electronic patient reported outcomes (ePRO), interactive voice response (IVR) and analytics to support the entire clinical trial process, from collection and cleaning to the integration and review of data. Our expertise includes studies from Phase I to post-approval for pharmaceutical, biotechnology and clinical research organizations. To date, our team of professionals has participated in over 450 clinical trials in more than 50 different countries.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
